136th ENMC International Workshop: Charcot–Marie–Tooth Disease Type 1A (CMT1A)8–10 April 2005, Naarden, The Netherlands
- 30 June 2006
- journal article
- Published by Elsevier BV in Neuromuscular Disorders
- Vol. 16 (6), 396-402
- https://doi.org/10.1016/j.nmd.2006.03.008
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth diseaseNature Medicine, 2004
- Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)Nature Medicine, 2003
- Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathiesJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Disease mechanisms and potential therapeutic strategies in Charcot–Marie–Tooth diseaseBrain Research Reviews, 2001
- Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.Human Molecular Genetics, 2001
- A Transgenic Rat Model of Charcot-Marie-Tooth DiseaseNeuron, 1996
- Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNAHuman Molecular Genetics, 1996
- Estimation of the Mutation Frequencies in Charcot-Marie-Tooth Disease Type 1 and Hereditary Neuropathy with Liability to Pressure Palsies: A European Collaborative StudyEuropean Journal of Human Genetics, 1996
- Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a)Neuromuscular Disorders, 1991
- DNA duplication associated with Charcot-Marie-Tooth disease type 1ACell, 1991